FDA OKs Low-Dose Colchicine for Broad CV Indication FDA OKs Low-Dose Colchicine for Broad CV Indication

The drug represents the first specific anti-inflammatory drug for the reduction of cardiovascular events for patients with established atherosclerotic disease or with multiple risk factors.Medscape Medical News
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Cardiology News Alert Source Type: news